EICHOR
● Recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Condition: Gastric Adenocarcinoma · Advanced Pancreatic Ductal Adenocarcinoma · Esophageal Adenocarcinoma · Sponsor: SystImmune Inc.
About this study
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
This description comes directly from the study's public registry record.
Talk to the study team
Stephanie Yee · 425.453.6841 · stephanie.yee@systimmune.com
Whitney Eakins · 425.453.6841 · whitney.eakins@systimmune.com
Always discuss trial participation with your own doctor first.
Locations (17)
| Mayo Clinic Cancer Center- Phoenix | Phoenix, Arizona, United States | Recruiting |
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| Valkyrie Clinical Trials | Los Angeles, California, United States | Recruiting |
| University of Colorado Health | Aurora, Colorado, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Ochsner Medical Center | New Orleans, Louisiana, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Not Yet Recruiting |
| Sarah Cannon Research Institute - Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville, Tennessee, United States | Not Yet Recruiting |
+ 5 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07021066